Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022)

Eur J Neurosci. 2023 Feb;57(3):456-457. doi: 10.1111/ejn.15872. Epub 2022 Dec 7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Excitatory Amino Acid Antagonists
  • Humans
  • Ketamine* / pharmacology
  • Psychotic Disorders* / drug therapy
  • Receptors, N-Methyl-D-Aspartate / physiology

Substances

  • Ketamine
  • Receptors, N-Methyl-D-Aspartate
  • Excitatory Amino Acid Antagonists